Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€124.90

€124.90

-0.400%
-0.5
-0.400%
-
 
19:34 / Tradegate WKN: 852738 / Symbol: UCBJF / Name: UCB SA / Stock / Pharmaceuticals / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

UCB S.A. Stock

The price for the UCB S.A. stock decreased slightly today. Compared to yesterday there is a change of -€0.500 (-0.400%).
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for UCB S.A. stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of UCB S.A. in the next few years

Pros
?
B****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
M***** P*******
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of UCB S.A. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
UCB S.A. -0.400% 4.849% 8.760% 43.577% 59.258% 56.437% 78.785%
Bayer AG ADR -3.790% -1.493% -3.650% -55.705% -23.256% -51.111% -58.228%
Roche Holding AG ADR 0.440% -0.892% -3.074% -22.984% -13.503% -20.187% -
GSK plc ADR 0.000% 3.243% -4.020% 13.018% 13.690% -2.051% -14.422%

Comments

UCB SA (OTCMKTS: UCBJF) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating.
Ratings data for UCBJF provided by MarketBeat
Show more

UCB SA (OTCMKTS: UCBJF) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.
Ratings data for UCBJF provided by MarketBeat
Show more

Buy UCB S.A.
Show more